LAVAL, Quebec, Feb. 6, 2018 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") will release its fourth-quarter and full-year 2017 financial results on Wednesday, Feb. 28, 2018. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.
Conference Call Details |
Date: | Wednesday, Feb. 28, 2018 |
Time: | 8:00 a.m. EST |
Webcast: | http://ir.valeant.com/events-and-presentations |
Participant Event Dial-in: | (844) 428-3520 (North America) |
| (409) 767-8386 (International) |
Participant Passcode: | 5287247 |
Replay Dial-in: | (855) 859-2056 (North America) |
| (404) 537-3406 (International) |
Replay Passcode: | 5287247 (replay available until Apr. 28, 2018) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-will-release-fourth-quarter-and-full-year-2017-financial-results-on-february-28-300594219.html
SOURCE Valeant Pharmaceuticals International, Inc.
